David Walk MD
Neuromuscular Medicine, Neurophysiology
Associate Professor, Neurology, University of Minnesota Medical School
Telehealth Available
Request Appointment516 Delaware St SE# PwbMinneapolis, MN 55455
Fax+1 612-273-4098
Overview of Dr. Walk
Dr. David Walk is a neurologist in Minneapolis, MN and is affiliated with M Health Fairview University of Minnesota Medical Center. He received his medical degree from The Warren Alpert Medical School of Brown University and has been in practice 33 years. Dr. Walk accepts several types of health insurance, listed below. He is one of 98 doctors at M Health Fairview University of Minnesota Medical Center who specialize in Neurology. He has more than 60 publications and over 500 citings.
Education & Training
University of ChicagoResidency, Neurology, 1986 - 1989
McGaw Medical Center of Northwestern UniversityInternship, Transitional Year, 1984 - 1985
The Warren Alpert Medical School of Brown UniversityClass of 1984
Certifications & Licensure
IL State Medical License 1986 - 2026
MN State Medical License 1999 - 2025
CT State Medical License 2021 - 2022
American Board of Psychiatry and Neurology Neurology- American Board of Psychiatry and Neurology Clinical Neurophysiology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Super Doctor SuperDoctors.com
Clinical Trials
- International Guillain-Barré Syndrome Outcome Study Start of enrollment: 2012 May 01
Publications & Presentations
PubMed
- Time-to-event prediction in ALS using a landmark modeling approach, using the ALS Natural History Consortium dataset.David Schneck, Andres Arguedas, Annette Xenopoulos-Oddsson, Ximena Arcila-Londono, Christian Lunetta
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2025-04-02 - Verdiperstat in Amyotrophic Lateral Sclerosis: Results From the Randomized HEALEY ALS Platform Trial., Jinsy Andrews, Sabrina Paganoni, Eric A Macklin, Lori B Chibnik
JAMA Neurology. 2025-02-17 - 2 citationsCNM-Au8 in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial., James D Berry, Nicholas J Maragakis, Eric A Macklin, Lori B Chibnik
JAMA. 2025-02-17
Press Mentions
Acceleron Announces Plans to Initiate a Phase 2 Trial of ACE-083 in Charcot-Marie-Tooth Neuromuscular Disease and Host Educational WebinarMarch 16th, 2017
Grant Support
- Multimodal longitudinal imaging of brain and cervical cord as an ALS disease biomarker using microstructure statistics and morphometryUNIVERSITY OF MINNESOTA2023–2027
- Clinic-based Multicenter ALS Natural History Data CollectionUNIVERSITY OF MINNESOTA2022–2027
- Clinic-based Multicenter ALS Natural History Data CollectionUNIVERSITY OF MINNESOTA2022–2027
- Clinic-based Multicenter ALS Natural History Data CollectionUNIVERSITY OF MINNESOTA2022–2027
- Clinic-based Multicenter ALS Natural History Data CollectionUNIVERSITY OF MINNESOTA2022–2027
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Illinois PPO
BCBS Minnesota Blue Cross Accord
BCBS Texas BlueChoice
CIGNA HMO
CIGNA Open Access
CIGNA PPOFirst Health PPO
Great West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
WEA Trust Preferred Provider Plan - Trust Pref - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
